Cargando…
Primary Immunodeficiency Diseases: Current and Emerging Therapeutics
Primary immunodeficiency diseases (PID) result from defects in genes affecting the immune and other systems in many and varied ways (1, 2). Until the last few years, treatments have been largely supportive, with the exception of bone marrow transplantation. However, recent advances in immunobiology,...
Autores principales: | Marciano, Beatriz E., Holland, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552668/ https://www.ncbi.nlm.nih.gov/pubmed/28848545 http://dx.doi.org/10.3389/fimmu.2017.00937 |
Ejemplares similares
-
Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency
por: Al-Herz, Waleed, et al.
Publicado: (2014) -
Corrigendum: Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency
por: Al-Herz, Waleed, et al.
Publicado: (2014) -
Current Perspectives and Unmet Needs of Primary Immunodeficiency Care in Asia Pacific
por: Leung, Daniel, et al.
Publicado: (2020) -
Reversion Mosaicism in Primary Immunodeficiency Diseases
por: Miyazawa, Hanae, et al.
Publicado: (2021) -
EBV-associated diseases: Current therapeutics and emerging technologies
por: Chakravorty, Srishti, et al.
Publicado: (2022)